Evaluation of Direct Medical Costs Associated With High-Risk Febrile Neutropenia Among Cancer Patients in a Tertiary Care Center. [PDF]
Bvsn S, Ravichandran M, Kayal S, S K.
europepmc +1 more source
Evaluation of a Febrile Neutropenia Protocol Implemented at Triage in an Emergency Department. [PDF]
Stramel-Stafford S +4 more
europepmc +1 more source
Kenan Aksu, Seçkin Çağırgan
openaire +2 more sources
Multinational association for supportive care in cancer (MASCC) versus clinical index of stable febrile neutropenia (CISNE): evaluation of predictive performance and clinical utility in patients with febrile neutropenia. [PDF]
Alpar S, Yılmaz S.
europepmc +1 more source
Predicting Bloodstream Infection in Pediatric Post-Transfusion Febrile Neutropenia: Development of a Simple Bedside Risk Score. [PDF]
Lee EJ +4 more
europepmc +1 more source
Lipegfilgrastim for primary prophylaxis of febrile neutropenia in patients treated for advanced-stage classical hodgkin lymphoma: successful outcomes from a multicenter cohort study. [PDF]
Giordano C +11 more
europepmc +1 more source
Risk Factors for Febrile Neutropenia in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Undergoing Initial R-CHOP Treatment. [PDF]
Chen LY +6 more
europepmc +1 more source
Effectiveness and safety of pegylated filgrastim (Pelgraz®) for the prevention of febrile neutropenia during cancer chemotherapy in all-day practice in Germany. [PDF]
Steinmetz T +8 more
europepmc +1 more source
CD48 as a Novel Early Biomarker Complementing Procalcitonin and Lactate for Predicting Bacteremia in Pediatric Febrile Neutropenia: A Prospective Cohort Study. [PDF]
Tahta N +7 more
europepmc +1 more source

